Islam J, Yano Y, Okamoto A, Matsuda R, Shiraishi M, Hashimoto Y
Sci Rep. 2024; 14(1):12066.
PMID: 38802465
PMC: 11130178.
DOI: 10.1038/s41598-024-62200-1.
Essaidi I, Bounder G, Jouimyi R, Boura H, Elyounsi I, Kheir F
Asian Pac J Cancer Prev. 2022; 23(8):2755-2761.
PMID: 36037131
PMC: 9741911.
DOI: 10.31557/APJCP.2022.23.8.2755.
Noh J, Ahn J, Choi J, Park Y, Na H, Lee J
Gut Liver. 2022; 17(3):375-381.
PMID: 35854654
PMC: 10191795.
DOI: 10.5009/gnl220076.
Yokota K, Osaki T, Hayashi S, Yokota S, Takeuchi H, Rimbara E
Helicobacter. 2022; 27(3):e12874.
PMID: 35255160
PMC: 9286379.
DOI: 10.1111/hel.12874.
Tshibangu-Kabamba E, Yamaoka Y
Nat Rev Gastroenterol Hepatol. 2021; 18(9):613-629.
PMID: 34002081
DOI: 10.1038/s41575-021-00449-x.
Best Eradication Strategy in the Era of Antibiotic Resistance.
Kim S, Chung J
Antibiotics (Basel). 2020; 9(8).
PMID: 32717826
PMC: 7459868.
DOI: 10.3390/antibiotics9080436.
Molecular typing of Treponema pallidum in the Czech Republic during 2011 to 2013: increased prevalence of identified genotypes and of isolates with macrolide resistance.
Grillova L, Petrosova H, Mikalova L, Strnadel R, Dastychova E, Kuklova I
J Clin Microbiol. 2014; 52(10):3693-700.
PMID: 25100820
PMC: 4187743.
DOI: 10.1128/JCM.01292-14.
Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia.
Trespalacios A, Otero W, Caminos J, Mercado M, Avila J, Rosero L
J Microbiol. 2013; 51(4):448-52.
PMID: 23990295
DOI: 10.1007/s12275-013-2465-6.
Characterization of clarithromycin resistance in isolates of Helicobacter pylori from the UAE.
Alfaresi M, Elkoush A
Indian J Gastroenterol. 2010; 29(3):116-20.
PMID: 20658326
DOI: 10.1007/s12664-010-0034-z.
Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.
Gibreel A, Kos V, Keelan M, Trieber C, Levesque S, Michaud S
Antimicrob Agents Chemother. 2005; 49(7):2753-9.
PMID: 15980346
PMC: 1168676.
DOI: 10.1128/AAC.49.7.2753-2759.2005.
T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori.
Burucoa C, Landron C, Garnier M, Fauchere J
Antimicrob Agents Chemother. 2005; 49(2):868.
PMID: 15673794
PMC: 547371.
DOI: 10.1128/AAC.49.2.868-870.2005.
Effect of glycine on Helicobacter pylori in vitro.
Minami M, Ando T, Hashikawa S, Torii K, Hasegawa T, Israel D
Antimicrob Agents Chemother. 2004; 48(10):3782-8.
PMID: 15388434
PMC: 521915.
DOI: 10.1128/AAC.48.10.3782-3788.2004.
T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh.
Khan R, Nahar S, Sultana J, Ahmad M, Rahman M
Antimicrob Agents Chemother. 2004; 48(9):3567-9.
PMID: 15328128
PMC: 514733.
DOI: 10.1128/AAC.48.9.3567-3569.2004.
Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil.
Ribeiro M, Vitiello L, Miranda M, Benvengo Y, Godoy A, Mendonca S
Ann Clin Microbiol Antimicrob. 2003; 2:11.
PMID: 14633281
PMC: 305369.
DOI: 10.1186/1476-0711-2-11.
Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis.
Alarcon T, Vega A, Domingo D, Martinez M, Lopez-Brea M
J Clin Microbiol. 2003; 41(1):486-99.
PMID: 12517902
PMC: 149579.
DOI: 10.1128/JCM.41.1.486-488.2003.